These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 20163297

  • 1. Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis.
    Sieber J, Köberlein J, Mösges R.
    Curr Med Res Opin; 2010 Apr; 26(4):925-32. PubMed ID: 20163297
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H.
    Allergy; 2009 Jan; 64(1):179-86. PubMed ID: 19076534
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
    Stelmach I, Kaczmarek-Woźniak J, Majak P, Olszowiec-Chlebna M, Jerzynska J.
    Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE, Bush RK, Peden D, Lockey RF.
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [Abstract] [Full Text] [Related]

  • 6. Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy.
    Sieber J, Shah-Hosseini K, Mösges R.
    Ann Med; 2011 May; 43(6):418-24. PubMed ID: 21679103
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W.
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [Abstract] [Full Text] [Related]

  • 8. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP, Ricciardi L, Isola S, Savi E, Parmiani S, Puccinelli P, Musarra A.
    Allergol Immunopathol (Madr); 1996 May; 24(4):146-51. PubMed ID: 8939269
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F, Agostinis F, Castella V, Kantar A, Novembre E, Perrone MR, Pietrasanta M, Sambugaro R, Milani M.
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G.
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [Abstract] [Full Text] [Related]

  • 11. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D, Gentile D, Bush R, Fasano MB, McLaughlin A, Esch RE.
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [Abstract] [Full Text] [Related]

  • 12. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
    Giordano T, Quarta C, Bruno ME, Falagiani P, Riva G.
    Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
    [Abstract] [Full Text] [Related]

  • 13. [Preventive immunotherapy].
    Boquete M, Carballada F, Expósito F, González A.
    Allergol Immunopathol (Madr); 2000 Nov; 28(3):89-93. PubMed ID: 10867376
    [Abstract] [Full Text] [Related]

  • 14. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B.
    Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H, White P, Annila I, Poole J, Andre C, Frew A.
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens.
    Quercia O, Bruno ME, Compalati E, Falagiani P, Mistrello G, Stefanini GF.
    Eur Ann Allergy Clin Immunol; 2011 Dec; 43(6):176-83. PubMed ID: 22360134
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.
    Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, Canonica GW.
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):141-8. PubMed ID: 16937742
    [Abstract] [Full Text] [Related]

  • 18. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O, Klimek L, Fischer I, Sieber J, Amoroso S, Moreno Aguilar C, Shah K, Mösges R.
    Int Arch Allergy Immunol; 2009 Aug; 150(1):102-8. PubMed ID: 19339808
    [Abstract] [Full Text] [Related]

  • 19. Efficacy, safety and tolerability of sublingual monomeric allergoid in tablets given without up-dosing to pediatric patients with allergic rhinitis and/or asthma due to grass pollen.
    Agostinis F, Foglia C, Bruno ME, Falagiani P.
    Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):177-80. PubMed ID: 20128231
    [Abstract] [Full Text] [Related]

  • 20. Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: the ECRIT study.
    Sieber J, Neis M, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Merk H.
    Expert Opin Drug Saf; 2012 Jan; 11(1):7-13. PubMed ID: 21980934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.